You just read:

Sierra Oncology to Present Innovative Clinical Trial Enhancements Leveraging Chk1 Synthetic Lethality in Two Posters at ASCO Annual Meeting

News provided by

Sierra Oncology

May 24, 2017, 07:00 ET